Trikafta 50-25-37.5 MG/75 MG UU 84S
Ended Awarded
- Contract number
- SPE2DB25FSZ02
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,474
Award facts
- Contract value 100% obligated
- $18,474.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,474.02 by the Defense Logistics Agency on July 28, 2025. The contract calls for the delivery of Trikafta 50-25-37.5 mg/75 mg tablets (84-count units), a prescription medication used in the treatment of cystic fibrosis. The award was issued without a set-aside designation and is scheduled for ultimate completion by July 29, 2025, with performance taking place at the contractor's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the issuance of firm fixed-price orders for pharmaceutical products supporting military health facilities worldwide. The contractor has demonstrated consistent success in securing federal pharmaceutical supply contracts and maintains a robust portfolio of delivery orders covering prescription medications, biologics, and medical consumables distributed to Department of Defense healthcare sites. This particular award reflects the ongoing operational pharmaceutical supply needs of the military healthcare system.
Quick answers
Who was awarded contract SPE2DB25FSZ02?
SPE2DB25FSZ02 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FSZ02 worth?
The government has obligated $18,474 on SPE2DB25FSZ02.
Is contract SPE2DB25FSZ02 an order under another contract?
Yes. SPE2DB25FSZ02 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB25FSZ02 competed?
The extent of competition for SPE2DB25FSZ02 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award